SCHEMBL4424894

SCHEMBL4424894

NC(=O)NCCC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15270205 0.91 EPHX1 (0.52)
SCHEMBL1440608 0.89 EPHX1 (0.59)
SCHEMBL22291007 0.86 ITGB3 (0.47)
SCHEMBL3811830 0.86 TDP1 (0.45)
SCHEMBL24577535 0.82 NCF1 (0.44)
SCHEMBL3420737 0.80 EPHX1 (0.59)
SCHEMBL20807437 0.78 TDP1 (0.42)
SCHEMBL8396810 0.78
SCHEMBL14435548 0.77 TDP1 (0.68)
SCHEMBL30990308 0.77 ACHE (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114867525-A Dihydrocyclopentaisoquinoline derivatives UCB生物制药有限责任公司 2022-08-05 CN claimed
CN-114867525-A Dihydrocyclopentaisoquinoline derivatives UCB生物制药有限责任公司 2022-08-05 CN disclosed
CN-101505752-B Prolyl hydroxylase inhibitors SMITHKLINE BEECHAM CORP 2012-12-05 CN disclosed
CN-101505752-A Prolyl hydroxylase inhibitors SMITHKLINE BEECHAM CORP (US) 2009-08-12 CN disclosed
EP-2037922-A2 PROLYL HYDROXYLASE INHIBITORS SmithKline Beecham Corporation (US) 2009-03-25 EP disclosed
WO-2007150011-A2 PROLYL HYDROXYLASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2007-12-27 WO disclosed
CN-1229350-C New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias ASTRAZENECA AB (SE) 2005-11-30 CN disclosed